Trulicity is not typically classified as a specialty drug by most insurance plans and pharmacy benefit managers. It is generally dispensed at regular retail pharmacies, not specialty pharmacies. However, its list price of roughly $1,007 per month and its injectable format give it some characteristics that overlap with specialty medications, which can cause confusion.
How Insurers Classify Trulicity
The distinction between a specialty drug and a standard brand-name drug comes down to how your insurer and pharmacy benefit manager (PBM) categorize it. CVS Specialty’s pharmacy distribution drug list, for example, does not include Trulicity. This means CVS does not route it through its specialty pharmacy channel. Most major insurers place Trulicity on a preferred or non-preferred brand tier rather than a specialty tier.
That said, formulary placement varies by plan. Some insurers do place GLP-1 receptor agonists like Trulicity on higher cost tiers that function similarly to specialty tiers, particularly as these medications have become more expensive. Your specific plan documents or formulary will tell you exactly which tier applies to you and what your copay or coinsurance will be.
Why It Gets Confused With Specialty Drugs
Several features of Trulicity check boxes that people associate with specialty medications. Its list price is $1,006.93 per month for a supply of four prefilled pens, according to manufacturer Eli Lilly. Under Medicare Part D, drugs that exceed a certain monthly cost threshold can be placed on a specialty tier, and Trulicity’s price is high enough to potentially qualify depending on the year’s threshold. For many commercial plans, drugs costing over $600 to $1,000 per month start getting flagged for specialty consideration.
Trulicity also requires cold chain handling. It must be stored in a refrigerator between 2°C and 8°C and cannot be frozen. Wholesalers, pharmacies, and mail-order companies are required to maintain refrigeration throughout shipping and storage. Patients can keep the pen at room temperature (below 30°C) for up to 14 days when refrigeration isn’t available, but that allowance applies only to patients, not to the supply chain. This kind of temperature-sensitive logistics is more common among specialty drugs than standard oral medications.
Trulicity is also an injectable, administered once weekly via a prefilled pen. Injectable self-administered medications are more likely to land in specialty categories than pills, though many injectable drugs (like insulin) remain available at retail pharmacies without specialty classification.
What Actually Makes a Drug “Specialty”
There is no single, universal definition of a specialty drug. The label generally applies to medications that meet several of the following criteria: high cost, complex storage or handling requirements, need for ongoing patient monitoring, limited distribution networks, or treatment of chronic or rare conditions. Specialty drugs are often dispensed through dedicated specialty pharmacies that provide patient support services, coordinate with insurers on prior authorizations, and manage cold chain shipping directly to patients’ homes.
Trulicity hits on cost and cold storage but falls short on other markers. It does not require infusion at a clinic. It does not need regular lab monitoring beyond what your prescriber would already do for diabetes management. And it is widely available at standard retail pharmacies like CVS, Walgreens, and Walmart, which is a strong signal that the industry treats it as a conventional brand-name drug rather than a specialty product.
Trulicity’s FDA Risk Program
The FDA did require a Risk Evaluation and Mitigation Strategy (REMS) for Trulicity at approval, focused on two safety concerns: a potential risk of medullary thyroid carcinoma and the risk of pancreatitis. However, this REMS consists only of a communication plan, meaning Eli Lilly sends informational letters, fact sheets, and maintains a website for prescribers. It does not require patients to enroll in a registry, undergo special testing, or fill the prescription through restricted pharmacies. This is a much lighter REMS than what you see with true specialty drugs, which sometimes require prescriber certification or mandatory blood tests before each refill.
What This Means for Your Out-of-Pocket Cost
Even though Trulicity is not a specialty drug in most formularies, it is still an expensive brand-name medication. Your cost depends heavily on your insurance plan’s tier placement and whether your plan requires prior authorization. Many plans place Trulicity on a preferred brand tier with a fixed copay, while others use coinsurance (a percentage of the drug’s cost), which can result in significantly higher out-of-pocket expenses.
If your insurer does place Trulicity on a specialty tier, you would likely face coinsurance of 25% to 33% rather than a flat copay, potentially meaning $250 or more per month before any assistance. Eli Lilly offers savings programs for commercially insured patients, and if you have Medicare Part D, the $2,000 annual out-of-pocket cap on prescription drug spending limits your total exposure regardless of tier placement.
The simplest way to check your plan’s classification is to look up Trulicity on your insurer’s online formulary tool or call the number on your pharmacy benefits card. The tier listed there determines your actual cost, regardless of whether the drug carries a “specialty” label industrywide.